Values First Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,904
| Closed | -$1.01M | – | 165 |
|
|
2022
Q2 | $1.01M | Buy |
6,904
+2,587
| +60% | +$377K | 0.71% | 47 |
|
|
2022
Q1 | $512K | Buy |
4,317
+315
| +8% | +$37.4K | 0.32% | 90 |
|
|
2021
Q4 | $552K | Sell |
4,002
-91
| -2% | -$12.6K | 0.33% | 93 |
|
|
2021
Q3 | $569K | Sell |
4,093
-2,398
| -37% | -$333K | 0.37% | 85 |
|
|
2021
Q2 | $630K | Buy |
6,491
+854
| +15% | +$82.9K | 0.43% | 83 |
|
|
2021
Q1 | $385K | Buy |
5,637
+768
| +16% | +$52.5K | 0.28% | 110 |
|
|
2020
Q4 | $417K | Buy |
4,869
+89
| +2% | +$7.62K | 0.33% | 99 |
|
|
2020
Q3 | $311K | Sell |
4,780
-1,895
| -28% | -$123K | 0.29% | 114 |
|
|
2020
Q2 | $488K | Sell |
6,675
-1,430
| -18% | -$105K | 0.48% | 72 |
|
|
2020
Q1 | $276K | Buy |
+8,105
| New | +$276K | 0.33% | 93 |
|